Teijin Pharma
- Business
Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
Osaka, Japan: sset transfer furthers Takeda’s global strategy to focus on five key business areas Takeda will continue to manufacture…
Read More »
Osaka, Japan: sset transfer furthers Takeda’s global strategy to focus on five key business areas Takeda will continue to manufacture…
Read More »